Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 XLIF Interbody Fusion Systems
1.2.3 XLIF Interbody Cages
1.3 Market by Application
1.3.1 Global Extreme Lateral Interbody Fusion (XLIF) Surgery Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Spinal Surgery Centers
1.3.3 Hospitals
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Extreme Lateral Interbody Fusion (XLIF) Surgery Market Perspective (2018-2033)
2.2 Extreme Lateral Interbody Fusion (XLIF) Surgery Growth Trends by Region
2.2.1 Global Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Extreme Lateral Interbody Fusion (XLIF) Surgery Historic Market Size by Region (2018-2023)
2.2.3 Extreme Lateral Interbody Fusion (XLIF) Surgery Forecasted Market Size by Region (2024-2033)
2.3 Extreme Lateral Interbody Fusion (XLIF) Surgery Market Dynamics
2.3.1 Extreme Lateral Interbody Fusion (XLIF) Surgery Industry Trends
2.3.2 Extreme Lateral Interbody Fusion (XLIF) Surgery Market Drivers
2.3.3 Extreme Lateral Interbody Fusion (XLIF) Surgery Market Challenges
2.3.4 Extreme Lateral Interbody Fusion (XLIF) Surgery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Extreme Lateral Interbody Fusion (XLIF) Surgery Players by Revenue
3.1.1 Global Top Extreme Lateral Interbody Fusion (XLIF) Surgery Players by Revenue (2018-2023)
3.1.2 Global Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue Market Share by Players (2018-2023)
3.2 Global Extreme Lateral Interbody Fusion (XLIF) Surgery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue
3.4 Global Extreme Lateral Interbody Fusion (XLIF) Surgery Market Concentration Ratio
3.4.1 Global Extreme Lateral Interbody Fusion (XLIF) Surgery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue in 2022
3.5 Extreme Lateral Interbody Fusion (XLIF) Surgery Key Players Head office and Area Served
3.6 Key Players Extreme Lateral Interbody Fusion (XLIF) Surgery Product Solution and Service
3.7 Date of Enter into Extreme Lateral Interbody Fusion (XLIF) Surgery Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Extreme Lateral Interbody Fusion (XLIF) Surgery Breakdown Data by Type
4.1 Global Extreme Lateral Interbody Fusion (XLIF) Surgery Historic Market Size by Type (2018-2023)
4.2 Global Extreme Lateral Interbody Fusion (XLIF) Surgery Forecasted Market Size by Type (2024-2033)
5 Extreme Lateral Interbody Fusion (XLIF) Surgery Breakdown Data by Application
5.1 Global Extreme Lateral Interbody Fusion (XLIF) Surgery Historic Market Size by Application (2018-2023)
5.2 Global Extreme Lateral Interbody Fusion (XLIF) Surgery Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size (2018-2033)
6.2 North America Extreme Lateral Interbody Fusion (XLIF) Surgery Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Country (2018-2023)
6.4 North America Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size (2018-2033)
7.2 Europe Extreme Lateral Interbody Fusion (XLIF) Surgery Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Country (2018-2023)
7.4 Europe Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size (2018-2033)
8.2 Asia-Pacific Extreme Lateral Interbody Fusion (XLIF) Surgery Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Region (2018-2023)
8.4 Asia-Pacific Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size (2018-2033)
9.2 Latin America Extreme Lateral Interbody Fusion (XLIF) Surgery Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Country (2018-2023)
9.4 Latin America Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size (2018-2033)
10.2 Middle East & Africa Extreme Lateral Interbody Fusion (XLIF) Surgery Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Country (2018-2023)
10.4 Middle East & Africa Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Medtronic Plc
11.1.1 Medtronic Plc Company Detail
11.1.2 Medtronic Plc Business Overview
11.1.3 Medtronic Plc Extreme Lateral Interbody Fusion (XLIF) Surgery Introduction
11.1.4 Medtronic Plc Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
11.1.5 Medtronic Plc Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Detail
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Extreme Lateral Interbody Fusion (XLIF) Surgery Introduction
11.2.4 Johnson & Johnson Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
11.2.5 Johnson & Johnson Recent Development
11.3 Stryker Corporation
11.3.1 Stryker Corporation Company Detail
11.3.2 Stryker Corporation Business Overview
11.3.3 Stryker Corporation Extreme Lateral Interbody Fusion (XLIF) Surgery Introduction
11.3.4 Stryker Corporation Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
11.3.5 Stryker Corporation Recent Development
11.4 Zimmer Biomet Holdings Inc.
11.4.1 Zimmer Biomet Holdings Inc. Company Detail
11.4.2 Zimmer Biomet Holdings Inc. Business Overview
11.4.3 Zimmer Biomet Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Introduction
11.4.4 Zimmer Biomet Holdings Inc. Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
11.4.5 Zimmer Biomet Holdings Inc. Recent Development
11.5 NuVasive Inc.
11.5.1 NuVasive Inc. Company Detail
11.5.2 NuVasive Inc. Business Overview
11.5.3 NuVasive Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Introduction
11.5.4 NuVasive Inc. Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
11.5.5 NuVasive Inc. Recent Development
11.6 Globus Medical Inc.
11.6.1 Globus Medical Inc. Company Detail
11.6.2 Globus Medical Inc. Business Overview
11.6.3 Globus Medical Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Introduction
11.6.4 Globus Medical Inc. Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
11.6.5 Globus Medical Inc. Recent Development
11.7 DePuy Synthes
11.7.1 DePuy Synthes Company Detail
11.7.2 DePuy Synthes Business Overview
11.7.3 DePuy Synthes Extreme Lateral Interbody Fusion (XLIF) Surgery Introduction
11.7.4 DePuy Synthes Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
11.7.5 DePuy Synthes Recent Development
11.8 B. Braun Melsungen AG
11.8.1 B. Braun Melsungen AG Company Detail
11.8.2 B. Braun Melsungen AG Business Overview
11.8.3 B. Braun Melsungen AG Extreme Lateral Interbody Fusion (XLIF) Surgery Introduction
11.8.4 B. Braun Melsungen AG Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
11.8.5 B. Braun Melsungen AG Recent Development
11.9 Alphatec Holdings Inc.
11.9.1 Alphatec Holdings Inc. Company Detail
11.9.2 Alphatec Holdings Inc. Business Overview
11.9.3 Alphatec Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Introduction
11.9.4 Alphatec Holdings Inc. Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
11.9.5 Alphatec Holdings Inc. Recent Development
11.10 RTI Surgical Holdings Inc.
11.10.1 RTI Surgical Holdings Inc. Company Detail
11.10.2 RTI Surgical Holdings Inc. Business Overview
11.10.3 RTI Surgical Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Introduction
11.10.4 RTI Surgical Holdings Inc. Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
11.10.5 RTI Surgical Holdings Inc. Recent Development
11.11 K2M Group Holdings Inc.
11.11.1 K2M Group Holdings Inc. Company Detail
11.11.2 K2M Group Holdings Inc. Business Overview
11.11.3 K2M Group Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Introduction
11.11.4 K2M Group Holdings Inc. Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
11.11.5 K2M Group Holdings Inc. Recent Development
11.12 Orthofix Medical Inc.
11.12.1 Orthofix Medical Inc. Company Detail
11.12.2 Orthofix Medical Inc. Business Overview
11.12.3 Orthofix Medical Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Introduction
11.12.4 Orthofix Medical Inc. Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
11.12.5 Orthofix Medical Inc. Recent Development
11.13 Aesculap Implant Systems
11.13.1 Aesculap Implant Systems Company Detail
11.13.2 Aesculap Implant Systems Business Overview
11.13.3 Aesculap Implant Systems Extreme Lateral Interbody Fusion (XLIF) Surgery Introduction
11.13.4 Aesculap Implant Systems Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
11.13.5 Aesculap Implant Systems Recent Development
11.14 SpineWave Inc.
11.14.1 SpineWave Inc. Company Detail
11.14.2 SpineWave Inc. Business Overview
11.14.3 SpineWave Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Introduction
11.14.4 SpineWave Inc. Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
11.14.5 SpineWave Inc. Recent Development
11.15 MicroPort Scientific Corporation
11.15.1 MicroPort Scientific Corporation Company Detail
11.15.2 MicroPort Scientific Corporation Business Overview
11.15.3 MicroPort Scientific Corporation Extreme Lateral Interbody Fusion (XLIF) Surgery Introduction
11.15.4 MicroPort Scientific Corporation Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
11.15.5 MicroPort Scientific Corporation Recent Development
11.16 Life Spine Inc.
11.16.1 Life Spine Inc. Company Detail
11.16.2 Life Spine Inc. Business Overview
11.16.3 Life Spine Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Introduction
11.16.4 Life Spine Inc. Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
11.16.5 Life Spine Inc. Recent Development
11.17 Captiva Spine Inc.
11.17.1 Captiva Spine Inc. Company Detail
11.17.2 Captiva Spine Inc. Business Overview
11.17.3 Captiva Spine Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Introduction
11.17.4 Captiva Spine Inc. Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
11.17.5 Captiva Spine Inc. Recent Development
11.18 CoreLink Surgical LLC
11.18.1 CoreLink Surgical LLC Company Detail
11.18.2 CoreLink Surgical LLC Business Overview
11.18.3 CoreLink Surgical LLC Extreme Lateral Interbody Fusion (XLIF) Surgery Introduction
11.18.4 CoreLink Surgical LLC Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
11.18.5 CoreLink Surgical LLC Recent Development
11.19 CTL Medical Corporation
11.19.1 CTL Medical Corporation Company Detail
11.19.2 CTL Medical Corporation Business Overview
11.19.3 CTL Medical Corporation Extreme Lateral Interbody Fusion (XLIF) Surgery Introduction
11.19.4 CTL Medical Corporation Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
11.19.5 CTL Medical Corporation Recent Development
11.20 Providence Medical Technology Inc.
11.20.1 Providence Medical Technology Inc. Company Detail
11.20.2 Providence Medical Technology Inc. Business Overview
11.20.3 Providence Medical Technology Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Introduction
11.20.4 Providence Medical Technology Inc. Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
11.20.5 Providence Medical Technology Inc. Recent Development
11.21 Safe Orthopaedics
11.21.1 Safe Orthopaedics Company Detail
11.21.2 Safe Orthopaedics Business Overview
11.21.3 Safe Orthopaedics Extreme Lateral Interbody Fusion (XLIF) Surgery Introduction
11.21.4 Safe Orthopaedics Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
11.21.5 Safe Orthopaedics Recent Development
11.22 Spinal Elements Holdings Inc.
11.22.1 Spinal Elements Holdings Inc. Company Detail
11.22.2 Spinal Elements Holdings Inc. Business Overview
11.22.3 Spinal Elements Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Introduction
11.22.4 Spinal Elements Holdings Inc. Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
11.22.5 Spinal Elements Holdings Inc. Recent Development
11.23 Spineology Inc.
11.23.1 Spineology Inc. Company Detail
11.23.2 Spineology Inc. Business Overview
11.23.3 Spineology Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Introduction
11.23.4 Spineology Inc. Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
11.23.5 Spineology Inc. Recent Development
11.24 Wenzel Spine Inc.
11.24.1 Wenzel Spine Inc. Company Detail
11.24.2 Wenzel Spine Inc. Business Overview
11.24.3 Wenzel Spine Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Introduction
11.24.4 Wenzel Spine Inc. Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
11.24.5 Wenzel Spine Inc. Recent Development
11.25 Xenco Medical.
11.25.1 Xenco Medical. Company Detail
11.25.2 Xenco Medical. Business Overview
11.25.3 Xenco Medical. Extreme Lateral Interbody Fusion (XLIF) Surgery Introduction
11.25.4 Xenco Medical. Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
11.25.5 Xenco Medical. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of XLIF Interbody Fusion Systems
Table 3. Key Players of XLIF Interbody Cages
Table 4. Global Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Extreme Lateral Interbody Fusion (XLIF) Surgery Market Share by Region (2018-2023)
Table 8. Global Extreme Lateral Interbody Fusion (XLIF) Surgery Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Extreme Lateral Interbody Fusion (XLIF) Surgery Market Share by Region (2024-2033)
Table 10. Extreme Lateral Interbody Fusion (XLIF) Surgery Market Trends
Table 11. Extreme Lateral Interbody Fusion (XLIF) Surgery Market Drivers
Table 12. Extreme Lateral Interbody Fusion (XLIF) Surgery Market Challenges
Table 13. Extreme Lateral Interbody Fusion (XLIF) Surgery Market Restraints
Table 14. Global Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Extreme Lateral Interbody Fusion (XLIF) Surgery Market Share by Players (2018-2023)
Table 16. Global Top Extreme Lateral Interbody Fusion (XLIF) Surgery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery as of 2022)
Table 17. Ranking of Global Top Extreme Lateral Interbody Fusion (XLIF) Surgery Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Extreme Lateral Interbody Fusion (XLIF) Surgery Product Solution and Service
Table 21. Date of Enter into Extreme Lateral Interbody Fusion (XLIF) Surgery Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue Market Share by Type (2018-2023)
Table 25. Global Extreme Lateral Interbody Fusion (XLIF) Surgery Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue Market Share by Type (2024-2033)
Table 27. Global Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue Market Share by Application (2018-2023)
Table 29. Global Extreme Lateral Interbody Fusion (XLIF) Surgery Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue Market Share by Application (2024-2033)
Table 31. North America Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Country (2024-2033) & (US$ Million)
Table 46. Medtronic Plc Company Detail
Table 47. Medtronic Plc Business Overview
Table 48. Medtronic Plc Extreme Lateral Interbody Fusion (XLIF) Surgery Product
Table 49. Medtronic Plc Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023) & (US$ Million)
Table 50. Medtronic Plc Recent Development
Table 51. Johnson & Johnson Company Detail
Table 52. Johnson & Johnson Business Overview
Table 53. Johnson & Johnson Extreme Lateral Interbody Fusion (XLIF) Surgery Product
Table 54. Johnson & Johnson Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023) & (US$ Million)
Table 55. Johnson & Johnson Recent Development
Table 56. Stryker Corporation Company Detail
Table 57. Stryker Corporation Business Overview
Table 58. Stryker Corporation Extreme Lateral Interbody Fusion (XLIF) Surgery Product
Table 59. Stryker Corporation Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023) & (US$ Million)
Table 60. Stryker Corporation Recent Development
Table 61. Zimmer Biomet Holdings Inc. Company Detail
Table 62. Zimmer Biomet Holdings Inc. Business Overview
Table 63. Zimmer Biomet Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product
Table 64. Zimmer Biomet Holdings Inc. Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023) & (US$ Million)
Table 65. Zimmer Biomet Holdings Inc. Recent Development
Table 66. NuVasive Inc. Company Detail
Table 67. NuVasive Inc. Business Overview
Table 68. NuVasive Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product
Table 69. NuVasive Inc. Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023) & (US$ Million)
Table 70. NuVasive Inc. Recent Development
Table 71. Globus Medical Inc. Company Detail
Table 72. Globus Medical Inc. Business Overview
Table 73. Globus Medical Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product
Table 74. Globus Medical Inc. Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023) & (US$ Million)
Table 75. Globus Medical Inc. Recent Development
Table 76. DePuy Synthes Company Detail
Table 77. DePuy Synthes Business Overview
Table 78. DePuy Synthes Extreme Lateral Interbody Fusion (XLIF) Surgery Product
Table 79. DePuy Synthes Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023) & (US$ Million)
Table 80. DePuy Synthes Recent Development
Table 81. B. Braun Melsungen AG Company Detail
Table 82. B. Braun Melsungen AG Business Overview
Table 83. B. Braun Melsungen AG Extreme Lateral Interbody Fusion (XLIF) Surgery Product
Table 84. B. Braun Melsungen AG Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023) & (US$ Million)
Table 85. B. Braun Melsungen AG Recent Development
Table 86. Alphatec Holdings Inc. Company Detail
Table 87. Alphatec Holdings Inc. Business Overview
Table 88. Alphatec Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product
Table 89. Alphatec Holdings Inc. Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023) & (US$ Million)
Table 90. Alphatec Holdings Inc. Recent Development
Table 91. RTI Surgical Holdings Inc. Company Detail
Table 92. RTI Surgical Holdings Inc. Business Overview
Table 93. RTI Surgical Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product
Table 94. RTI Surgical Holdings Inc. Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023) & (US$ Million)
Table 95. RTI Surgical Holdings Inc. Recent Development
Table 96. K2M Group Holdings Inc. Company Detail
Table 97. K2M Group Holdings Inc. Business Overview
Table 98. K2M Group Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product
Table 99. K2M Group Holdings Inc. Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023) & (US$ Million)
Table 100. K2M Group Holdings Inc. Recent Development
Table 101. Orthofix Medical Inc. Company Detail
Table 102. Orthofix Medical Inc. Business Overview
Table 103. Orthofix Medical Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product
Table 104. Orthofix Medical Inc. Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023) & (US$ Million)
Table 105. Orthofix Medical Inc. Recent Development
Table 106. Aesculap Implant Systems Company Detail
Table 107. Aesculap Implant Systems Business Overview
Table 108. Aesculap Implant Systems Extreme Lateral Interbody Fusion (XLIF) Surgery Product
Table 109. Aesculap Implant Systems Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023) & (US$ Million)
Table 110. Aesculap Implant Systems Recent Development
Table 111. SpineWave Inc. Company Detail
Table 112. SpineWave Inc. Business Overview
Table 113. SpineWave Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product
Table 114. SpineWave Inc. Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023) & (US$ Million)
Table 115. SpineWave Inc. Recent Development
Table 116. MicroPort Scientific Corporation Company Detail
Table 117. MicroPort Scientific Corporation Business Overview
Table 118. MicroPort Scientific Corporation Extreme Lateral Interbody Fusion (XLIF) Surgery Product
Table 119. MicroPort Scientific Corporation Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023) & (US$ Million)
Table 120. MicroPort Scientific Corporation Recent Development
Table 121. Life Spine Inc. Company Detail
Table 122. Life Spine Inc. Business Overview
Table 123. Life Spine Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product
Table 124. Life Spine Inc. Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023) & (US$ Million)
Table 125. Life Spine Inc. Recent Development
Table 126. Captiva Spine Inc. Company Detail
Table 127. Captiva Spine Inc. Business Overview
Table 128. Captiva Spine Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product
Table 129. Captiva Spine Inc. Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023) & (US$ Million)
Table 130. Captiva Spine Inc. Recent Development
Table 131. CoreLink Surgical LLC Company Detail
Table 132. CoreLink Surgical LLC Business Overview
Table 133. CoreLink Surgical LLC Extreme Lateral Interbody Fusion (XLIF) Surgery Product
Table 134. CoreLink Surgical LLC Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023) & (US$ Million)
Table 135. CoreLink Surgical LLC Recent Development
Table 136. CTL Medical Corporation Company Detail
Table 137. CTL Medical Corporation Business Overview
Table 138. CTL Medical Corporation Extreme Lateral Interbody Fusion (XLIF) Surgery Product
Table 139. CTL Medical Corporation Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023) & (US$ Million)
Table 140. CTL Medical Corporation Recent Development
Table 141. Providence Medical Technology Inc. Company Detail
Table 142. Providence Medical Technology Inc. Business Overview
Table 143. Providence Medical Technology Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product
Table 144. Providence Medical Technology Inc. Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023) & (US$ Million)
Table 145. Providence Medical Technology Inc. Recent Development
Table 146. Safe Orthopaedics Company Detail
Table 147. Safe Orthopaedics Business Overview
Table 148. Safe Orthopaedics Extreme Lateral Interbody Fusion (XLIF) Surgery Product
Table 149. Safe Orthopaedics Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023) & (US$ Million)
Table 150. Safe Orthopaedics Recent Development
Table 151. Spinal Elements Holdings Inc. Company Detail
Table 152. Spinal Elements Holdings Inc. Business Overview
Table 153. Spinal Elements Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product
Table 154. Spinal Elements Holdings Inc. Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023) & (US$ Million)
Table 155. Spinal Elements Holdings Inc. Recent Development
Table 156. Spineology Inc. Company Detail
Table 157. Spineology Inc. Business Overview
Table 158. Spineology Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product
Table 159. Spineology Inc. Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023) & (US$ Million)
Table 160. Spineology Inc. Recent Development
Table 161. Wenzel Spine Inc. Company Detail
Table 162. Wenzel Spine Inc. Business Overview
Table 163. Wenzel Spine Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product
Table 164. Wenzel Spine Inc. Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023) & (US$ Million)
Table 165. Wenzel Spine Inc. Recent Development
Table 166. Xenco Medical. Company Detail
Table 167. Xenco Medical. Business Overview
Table 168. Xenco Medical. Extreme Lateral Interbody Fusion (XLIF) Surgery Product
Table 169. Xenco Medical. Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023) & (US$ Million)
Table 170. Xenco Medical. Recent Development
Table 171. Research Programs/Design for This Report
Table 172. Key Data Information from Secondary Sources
Table 173. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Extreme Lateral Interbody Fusion (XLIF) Surgery Market Share by Type: 2022 VS 2033
Figure 3. XLIF Interbody Fusion Systems Features
Figure 4. XLIF Interbody Cages Features
Figure 5. Global Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Extreme Lateral Interbody Fusion (XLIF) Surgery Market Share by Application: 2022 VS 2033
Figure 7. Spinal Surgery Centers Case Studies
Figure 8. Hospitals Case Studies
Figure 9. Others Case Studies
Figure 10. Extreme Lateral Interbody Fusion (XLIF) Surgery Report Years Considered
Figure 11. Global Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Extreme Lateral Interbody Fusion (XLIF) Surgery Market Share by Region: 2022 VS 2033
Figure 14. Global Extreme Lateral Interbody Fusion (XLIF) Surgery Market Share by Players in 2022
Figure 15. Global Top Extreme Lateral Interbody Fusion (XLIF) Surgery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue in 2022
Figure 17. North America Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Extreme Lateral Interbody Fusion (XLIF) Surgery Market Share by Country (2018-2033)
Figure 19. United States Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Extreme Lateral Interbody Fusion (XLIF) Surgery Market Share by Country (2018-2033)
Figure 23. Germany Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Extreme Lateral Interbody Fusion (XLIF) Surgery Market Share by Region (2018-2033)
Figure 31. China Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Extreme Lateral Interbody Fusion (XLIF) Surgery Market Share by Country (2018-2033)
Figure 39. Mexico Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Extreme Lateral Interbody Fusion (XLIF) Surgery Market Share by Country (2018-2033)
Figure 43. Turkey Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Medtronic Plc Revenue Growth Rate in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
Figure 46. Johnson & Johnson Revenue Growth Rate in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
Figure 47. Stryker Corporation Revenue Growth Rate in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
Figure 48. Zimmer Biomet Holdings Inc. Revenue Growth Rate in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
Figure 49. NuVasive Inc. Revenue Growth Rate in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
Figure 50. Globus Medical Inc. Revenue Growth Rate in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
Figure 51. DePuy Synthes Revenue Growth Rate in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
Figure 52. B. Braun Melsungen AG Revenue Growth Rate in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
Figure 53. Alphatec Holdings Inc. Revenue Growth Rate in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
Figure 54. RTI Surgical Holdings Inc. Revenue Growth Rate in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
Figure 55. K2M Group Holdings Inc. Revenue Growth Rate in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
Figure 56. Orthofix Medical Inc. Revenue Growth Rate in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
Figure 57. Aesculap Implant Systems Revenue Growth Rate in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
Figure 58. SpineWave Inc. Revenue Growth Rate in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
Figure 59. MicroPort Scientific Corporation Revenue Growth Rate in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
Figure 60. Life Spine Inc. Revenue Growth Rate in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
Figure 61. Captiva Spine Inc. Revenue Growth Rate in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
Figure 62. CoreLink Surgical LLC Revenue Growth Rate in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
Figure 63. CTL Medical Corporation Revenue Growth Rate in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
Figure 64. Providence Medical Technology Inc. Revenue Growth Rate in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
Figure 65. Safe Orthopaedics Revenue Growth Rate in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
Figure 66. Spinal Elements Holdings Inc. Revenue Growth Rate in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
Figure 67. Spineology Inc. Revenue Growth Rate in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
Figure 68. Wenzel Spine Inc. Revenue Growth Rate in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
Figure 69. Xenco Medical. Revenue Growth Rate in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed